Skip to main content

Chlamydia trachomatis fails to protect its growth niche against pro-apoptotic insults.

Publication ,  Journal Article
Sixt, BS; Núñez-Otero, C; Kepp, O; Valdivia, RH; Kroemer, G
Published in: Cell Death Differ
August 2019

Chlamydia trachomatis is an obligate intracellular bacterial agent responsible for ocular infections and sexually transmitted diseases. It has been postulated that Chlamydia inhibits apoptosis in host cells to maintain an intact replicative niche until sufficient infectious progeny can be generated. Here we report that, while cells infected with C. trachomatis are protected from apoptosis at early and mid-stages of infection, they remain susceptible to the induction of other cell death modalities. By monitoring the fate of infected cells by time-lapse video microscopy and by analyzing host plasma membrane integrity and the activity of caspases, we determined that C. trachomatis-infected cells exposed to pro-apoptotic stimuli predominately died by a mechanism resembling necrosis. This necrotic death of infected cells occurred with kinetics similar to the induction of apoptosis in uninfected cells, indicating that C. trachomatis fails to considerably prolong the lifespan of its host cell when exposed to pro-apoptotic insults. Inhibitors of bacterial protein synthesis partially blocked necrotic death of infected cells, suggesting that the switch from apoptosis to necrosis relies on an active contribution of the bacteria. Tumor necrosis factor alpha (TNF-α)-mediated induction of necrosis in cells infected with C. trachomatis was not dependent on canonical regulators of necroptosis, such as RIPK1, RIPK3, or MLKL, yet was blocked by inhibition or depletion of CASP8. These results suggest that alternative signaling pathways regulate necrotic death in the context of C. trachomatis infections. Finally, consistent with the inability of C. trachomatis to preserve host cell viability, necrosis resulting from pro-apoptotic conditions significantly impaired production of infectious progeny. Taken together, our findings suggest that Chlamydia's anti-apoptotic activities are not sufficient to protect the pathogen's replicative niche.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Cell Death Differ

DOI

EISSN

1476-5403

Publication Date

August 2019

Volume

26

Issue

8

Start / End Page

1485 / 1500

Location

England

Related Subject Headings

  • Staurosporine
  • Humans
  • Hela Cells
  • HeLa Cells
  • Chlamydia trachomatis
  • Biochemistry & Molecular Biology
  • Apoptosis
  • Anti-Bacterial Agents
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Sixt, B. S., Núñez-Otero, C., Kepp, O., Valdivia, R. H., & Kroemer, G. (2019). Chlamydia trachomatis fails to protect its growth niche against pro-apoptotic insults. Cell Death Differ, 26(8), 1485–1500. https://doi.org/10.1038/s41418-018-0224-2
Sixt, Barbara S., Carlos Núñez-Otero, Oliver Kepp, Raphael H. Valdivia, and Guido Kroemer. “Chlamydia trachomatis fails to protect its growth niche against pro-apoptotic insults.Cell Death Differ 26, no. 8 (August 2019): 1485–1500. https://doi.org/10.1038/s41418-018-0224-2.
Sixt BS, Núñez-Otero C, Kepp O, Valdivia RH, Kroemer G. Chlamydia trachomatis fails to protect its growth niche against pro-apoptotic insults. Cell Death Differ. 2019 Aug;26(8):1485–500.
Sixt, Barbara S., et al. “Chlamydia trachomatis fails to protect its growth niche against pro-apoptotic insults.Cell Death Differ, vol. 26, no. 8, Aug. 2019, pp. 1485–500. Pubmed, doi:10.1038/s41418-018-0224-2.
Sixt BS, Núñez-Otero C, Kepp O, Valdivia RH, Kroemer G. Chlamydia trachomatis fails to protect its growth niche against pro-apoptotic insults. Cell Death Differ. 2019 Aug;26(8):1485–1500.

Published In

Cell Death Differ

DOI

EISSN

1476-5403

Publication Date

August 2019

Volume

26

Issue

8

Start / End Page

1485 / 1500

Location

England

Related Subject Headings

  • Staurosporine
  • Humans
  • Hela Cells
  • HeLa Cells
  • Chlamydia trachomatis
  • Biochemistry & Molecular Biology
  • Apoptosis
  • Anti-Bacterial Agents
  • 42 Health sciences
  • 32 Biomedical and clinical sciences